Clinical Trials

Heart disease study in patients with type 2 diabetes

Posted on 7/25/2019

This study is being done to assess whether the type 2 diabetes medicine, semaglitide, has a positive effect on heart disease.  This will be done by comparing it to placebo (no active ingredients).  This will be an oral tablet taken daily in the morning on an empty stomach.

You may qualify for this study if you:
  • Have type 2 diabetes
  • Have or had heart disease, certain diseases of the arteries and /or kidney disease
  • Are at least 50 years of age 

The study duration is approximately 3-5 years.  There will be 25 visits to the clinic, however after the first 3 months, you will only come to the clinic every 3 months.

There will be no charge for participating in the study.  The study medication, study materials and study specific visits will be provided at no charge to you or your insurance company. 

If you qualify and decide to participate you will be compensated for your time and travel while participating in the study.  

You will receive $50 for each study visit for a total of up to $1,300.

Call our office for more information - (903) 238-8854
What Our Research Patients are Saying
"I was on edge when I first went to DCOL Research because of the sensitive nature of my diagnosis. Upon arrival to the research office I was treated very kindly and professionally as soon as I signed in. The Research Coordinator was friendly and compassionate and made me feel at ease. I was informed about the trial and they ensured that I had a clear understanding of the information. During all my visits I felt at ease and informed. The Research Coordinator is very professional as is the Lab Coordinator. It is always a smooth process and the staff is confident and friendly. The study doctor is also helpful and always asks if I have any problems or concerns, just like the staff."

~ Anonymous

Contact Form


  
DCOL of Longview